We previously demonstrated that induction of FOXO3a was involved in the berberine- and curcumin-inhibited growth and induced apoptosis in NSCLC and nasopharyngeal carcinoma cells [19, 21]. The gene discussed is FOXO3; the disease is nasopharyngeal carcinoma.